This protocol is judged by an institutional assessment board, an impartial group that testimonials any clinical trials involving human beings. If a review includes a Routine I drug, as soon as the board approves the protocol as ethical, the researchers really need to make an application for an investigational new drug (IND) quantity within the FDA